Baxter: Stifel raises target price to $24 from $19
BAX•Related News
3D Systems Enables First FDA Clearance For Implant From A Point-Of-Care Institution
DDD•
GSK now expects 20+ phase III trial starts in 2026, up from 10
GSK•
Firefly Neuroscience partners with Next Health on precision cognitive health platform
AIFF•
Twilio Inc <TWLO.N>: BTIG raises target price to $245 from $215
TWLO•
Chevron Corp <CVX.N>: BofA Global Research raises price objective to $227 from $210
CVX•